A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy

The current understanding on the clinical efficacy of Rho-associated protein kinase (ROCK) inhibitor for treating Fuchs endothelial corneal dystrophy is summarized to clarify whether the “off-label” ROCK-inhibitor eye-drop application are appropriate. ROCK-inhibitor eye drops may eventually be deeme...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinoshita, Shigeru, Colby, Kathryn A., Kruse, Friedrich E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2021
Materias:
Invited Submission
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423139/
https://www.ncbi.nlm.nih.gov/pubmed/34481406
http://dx.doi.org/10.1097/ICO.0000000000002642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423139/
https://www.ncbi.nlm.nih.gov/pubmed/34481406
http://dx.doi.org/10.1097/ICO.0000000000002642

Ejemplares similares